181 related articles for article (PubMed ID: 8314986)
1. Detection of antibodies to a pathogenic mycoplasma in desert tortoises (Gopherus agassizii) with upper respiratory tract disease.
Schumacher IM; Brown MB; Jacobson ER; Collins BR; Klein PA
J Clin Microbiol; 1993 Jun; 31(6):1454-60. PubMed ID: 8314986
[TBL] [Abstract][Full Text] [Related]
2. Western blot can distinguish natural and acquired antibodies to Mycoplasma agassizii in the desert tortoise (Gopherus agassizii).
Hunter KW; Dupré SA; Sharp T; Sandmeier FC; Tracy CR
J Microbiol Methods; 2008 Dec; 75(3):464-71. PubMed ID: 18708096
[TBL] [Abstract][Full Text] [Related]
3. Upper respiratory tract disease in the gopher tortoise is caused by Mycoplasma agassizii.
Brown MB; McLaughlin GS; Klein PA; Crenshaw BC; Schumacher IM; Brown DR; Jacobson ER
J Clin Microbiol; 1999 Jul; 37(7):2262-9. PubMed ID: 10364595
[TBL] [Abstract][Full Text] [Related]
4. Mycoplasmosis in free-ranging desert tortoises in Utah and Arizona.
Dickinson VM; Schumacher IM; Jarchow JL; Duck T; Schwalbe CR
J Wildl Dis; 2005 Oct; 41(4):839-42. PubMed ID: 16456181
[TBL] [Abstract][Full Text] [Related]
5. Persistence of maternal antibodies against Mycoplasma agassizii in desert tortoise hatchlings.
Schumacher IM; Rostal DC; Yates RA; Brown DR; Jacobson ER; Klein PA
Am J Vet Res; 1999 Jul; 60(7):826-31. PubMed ID: 10407474
[TBL] [Abstract][Full Text] [Related]
6. Mycoplasma testudineum in free-ranging desert tortoises, Gopherus agassizii.
Jacobson ER; Berry KH
J Wildl Dis; 2012 Oct; 48(4):1063-8. PubMed ID: 23060510
[TBL] [Abstract][Full Text] [Related]
7. Molecular methods to detect Mycoplasma spp. And Testudinid herpesvirus 2 in desert tortoises (Gopherus agassizii) and implications for disease management.
Braun J; Schrenzel M; Witte C; Gokool L; Burchell J; Rideout BA
J Wildl Dis; 2014 Oct; 50(4):757-66. PubMed ID: 25121400
[TBL] [Abstract][Full Text] [Related]
8. Relationship between clinical signs of upper respiratory tract disease and antibodies to Mycoplasma agassizii in desert tortoises from Nevada.
Schumacher IM; Hardenbrook DB; Brown MB; Jacobson ER; Klein PA
J Wildl Dis; 1997 Apr; 33(2):261-6. PubMed ID: 9131556
[TBL] [Abstract][Full Text] [Related]
9. Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise.
Brown MB; Schumacher IM; Klein PA; Harris K; Correll T; Jacobson ER
Infect Immun; 1994 Oct; 62(10):4580-6. PubMed ID: 7927724
[TBL] [Abstract][Full Text] [Related]
10. Detection of Mycoplasma agassizii in the Texas tortoise (Gopherus berlandieri).
Guthrie AL; White CL; Brown MB; deMaar TW
J Wildl Dis; 2013 Jul; 49(3):704-8. PubMed ID: 23778626
[TBL] [Abstract][Full Text] [Related]
11. Upper respiratory tract disease and associated diagnostic tests of mycoplasmosis in Alabama populations of Gopher tortoises, Gopherus polyphemus.
Goessling JM; Guyer C; Godwin JC; Hermann SM; Sandmeier FC; Smith LL; Mendonça MT
PLoS One; 2019; 14(4):e0214845. PubMed ID: 30951541
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of upper respiratory tract disease in the desert tortoise in the western Mojave Desert of California.
Brown MB; Berry KH; Schumacher IM; Nagy KA; Christopher MM; Klein PA
J Wildl Dis; 1999 Oct; 35(4):716-27. PubMed ID: 10574531
[TBL] [Abstract][Full Text] [Related]
13. ASSESSMENT OF DISEASE RISK ASSOCIATED WITH POTENTIAL REMOVAL OF ANTHROPOGENIC BARRIERS TO MOJAVE DESERT TORTOISE (GOPHERUS AGASSIZII) POPULATION CONNECTIVITY.
Burgess TL; Braun J; Witte CL; Lamberski N; Field KJ; Allison LJ; Averill-Murray RC; Drake KK; Nussear KE; Esque TC; Rideout BA
J Wildl Dis; 2021 Jul; 57(3):579-589. PubMed ID: 34019673
[TBL] [Abstract][Full Text] [Related]
14. Mycoplasmal upper respiratory tract disease across the range of the threatened Mojave Desert tortoise: associations with thermal regime and natural antibodies.
Sandmeier FC; Tracy CR; Hagerty BE; DuPré S; Mohammadpour H; Hunter K
Ecohealth; 2013 Mar; 10(1):63-71. PubMed ID: 23579813
[TBL] [Abstract][Full Text] [Related]
15. Upper respiratory tract disease and mycoplasmosis in desert tortoises from Nevada.
Lederle PE; Rautenstrauch KR; Rakestraw DL; Zander KK; Boone JL
J Wildl Dis; 1997 Oct; 33(4):759-65. PubMed ID: 9391959
[TBL] [Abstract][Full Text] [Related]
16. Effects of mycoplasmal upper respiratory tract disease on morbidity and mortality of gopher tortoises in northern and central Florida.
Berish JE; Wendland LD; Kiltie RA; Garrison EP; Gates CA
J Wildl Dis; 2010 Jul; 46(3):695-705. PubMed ID: 20688675
[TBL] [Abstract][Full Text] [Related]
17. Mycoplasma agassizii strain variation and distinct host antibody responses explain differences between enzyme-linked immunosorbent assays and Western blot assays.
Wendland LD; Klein PA; Jacobson ER; Brown MB
Clin Vaccine Immunol; 2010 Nov; 17(11):1739-45. PubMed ID: 20810678
[TBL] [Abstract][Full Text] [Related]
18. Quantitative PCR method for detection of mycoplasma spp. DNA in nasal lavage samples from the desert tortoise (Gopherus agassizii).
duPre' SA; Tracy CR; Hunter KW
J Microbiol Methods; 2011 Aug; 86(2):160-5. PubMed ID: 21565225
[TBL] [Abstract][Full Text] [Related]
19. Clinical disease and laboratory abnormalities in free-ranging desert tortoises in California (1990-1995).
Christopher MM; Berry KH; Henen BT; Nagy KA
J Wildl Dis; 2003 Jan; 39(1):35-56. PubMed ID: 12685067
[TBL] [Abstract][Full Text] [Related]
20. Pathology of upper respiratory tract disease of gopher tortoises in Florida.
McLaughlin GS; Jacobson ER; Brown DR; McKenna CE; Schumacher IM; Adams HP; Brown MB; Klein PA
J Wildl Dis; 2000 Apr; 36(2):272-83. PubMed ID: 10813609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
